drugset / Trial / NCT01981447
IV Lacosamide: The Safety of Intravenous Lacosamide
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety of IV Lacosamide in children ages 4-35.
Timeline
- Start
- 2010-04
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lacosamide | Other / unclassified | 0.7 mg/kg | Intravenous |
| Comparator | Lacosamide | Other / unclassified | 1.4 mg/kg | Intravenous |
| Comparator | Lacosamide | Other / unclassified | 2.1 mg/kg | Intravenous |
| Comparator | Lacosamide | Other / unclassified | 2.4 mg/kg | Intravenous |
| Comparator | Lacosamide | Other / unclassified | 2.9 mg/kg | Intravenous |